Search results
GSK blood cancer drug nearly halves risk of death in late-stage trial
KFGO· 6 days agoBy Pratik Jain (Reuters) - GSK's multiple myeloma drug Blenrep nearly halved the risk of disease...
Neoadjuvant Strategy Establishes Standard of Care for Resectable Stage III Melanoma
MedPage Today· 4 days agoCombination neoadjuvant immunotherapy for resectable melanoma reduced recurrence and other clinical...
Phase 2 Study Shows Opdivo-Yervoy Highly Effective In Colon Cancer
Forbes· 1 day agoA four-week course of dual immunotherapy prior to surgery is highly effective in treating a certain...
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 6 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
Buy Alert: 3 Penny Stocks That Will Explode in 2024
InvestorPlace· 3 days agoWhen the term penny stocks to buy is thrown around, ideas of high-risk-high-reward, overnight wealth generation and potential scams may come to mind....
Geron surges after winning first US FDA approval for blood disorder drug
AOL· 1 day ago(Reuters) -Shares of Geron surged more than 20% on Friday, a day after the company gained its first approval from the U.S. Food and Drug Administration for its blood disorder drug. The health ...
Why Is Mid-Cap Cancer-Focused Replimune Stock Trading Higher On Thursday?
Benzinga· 2 days agoThursday, Replimune Group Inc REPL released topline results from the primary analysis of the IGNYTE clinical trial of RP1 plus nivolumab in anti-PD1 failed melanoma. Bristol-Myers Squibb Co’ ...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 7 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed...
Replimune up 30% on results for RP1 combo in melanoma (NASDAQ:REPL)
Seeking Alpha· 2 days agoReplimmune Group reports positive results in melanoma patients who failed on PD-1 inhibitors,...
ASCO 2024: Precede Biosciences assay classifies HER2 and ER status in cancers
Medical Device Network via Yahoo Finance· 5 days agoPrecede Biosciences has announced positive results for its novel liquid biopsy assay, which can...